Davita - Portage in Portage, Indiana - Dialysis Center

Davita - Portage is a medicare approved dialysis facility center in Portage, Indiana and it has 16 dialysis stations. It is located in Porter county at 5823 Us Hwy 6, Portage, IN, 46368. You can reach out to the office of Davita - Portage at (219) 764-0564. This dialysis clinic is managed and/or owned by Davita. Davita - Portage has the following ownership type - Profit. It was first certified by medicare in October, 2008. The medicare id for this facility is 152630 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameDavita - Portage
Location5823 Us Hwy 6, Portage, Indiana
No. of Dialysis Stations 16
Medicare ID152630
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


5823 Us Hwy 6, Portage, Indiana, 46368
(219) 764-0564

News Archive

Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

Medical marijuana dispensaries going corporate

Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

Read more Medical News

› Verified 5 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Davita - Portage from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1588822688
Organization NamePortage Dialysis
Doing Business AsTotal Renal Care Inc
Address5823 Us Highway 6 Portage, Indiana, 46368
Phone Number(219) 764-0564

News Archive

Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

Medical marijuana dispensaries going corporate

Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

Read more Medical News

› Verified 5 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data41
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL20

News Archive

Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

Medical marijuana dispensaries going corporate

Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

Read more Medical News

› Verified 5 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center61
    Adult patient months included in Kt/V greater than or equal to 1.2546
    Percentage of adult patients getting regular hemodialysis at the center95
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

    A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

    Medical marijuana dispensaries going corporate

    Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

    Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

    Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

    Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

    Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

    BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

    An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

    Read more Medical News

    › Verified 5 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center11
    Adult patient months included in Kt/V greater than or equal to 1.797
    Percentage of adult patients getting regular peritoneal dialysis at the center95
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

    A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

    Medical marijuana dispensaries going corporate

    Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

    Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

    Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

    Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

    Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

    BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

    An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

    Read more Medical News

    › Verified 5 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Portage with elevated calcium levels.

Patients with hypercalcemia83
Hypercalcemia patient months712
Patients with Serumphosphor84
Patients with Serumphosphor less than 3.5 mg/dL8
Patients with Serumphosphor from 3.5 to 4.5 mg/dL21
Patients with Serumphosphor from 4.6 to 5.5 mg/dL33
Patients with Serumphosphor from 5.6 to 7 mg/dL23
Patients with Serumphosphor greater than 7 mg/dL15

News Archive

Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

Medical marijuana dispensaries going corporate

Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

Read more Medical News

› Verified 5 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 57
Patient months included in arterial venous fistula and catheter summaries 430
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment71
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer14

News Archive

Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

Medical marijuana dispensaries going corporate

Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

Read more Medical News

› Verified 5 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary64
Hospitalization Rate in facility134.7 (As Expected)
Hospitalization Rate: Upper Confidence Limit247.2
Hospitalization Rate: Lower Confidence Limit75.9

News Archive

Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

Medical marijuana dispensaries going corporate

Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

Read more Medical News

› Verified 5 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Davita - Portage were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility22 (As Expected)
Readmission Rate: Upper Confidence Limit33.4
Readmission Rate: Lower Confidence Limit13.1

News Archive

Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

Medical marijuana dispensaries going corporate

Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

Read more Medical News

› Verified 5 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Portage get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility1.08 (As Expected)
SIR: Upper Confidence Limit2.6
SIR: Lower Confidence Limit.34

News Archive

Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

Medical marijuana dispensaries going corporate

Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

Read more Medical News

› Verified 5 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Portage's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 54
Transfusion Rate in facility20.9 (As Expected)
Transfusion Rate: Upper Confidence Limit67.9
Transfusion Rate: Lower Confidence Limit7.4

News Archive

Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

Medical marijuana dispensaries going corporate

Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

Read more Medical News

› Verified 5 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Davita - Portage lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary309
Mortality Rate in facility13.3 (As Expected)
Mortality Rate: Upper Confidence Limit18.5
Mortality Rate: Lower Confidence Limit9.3

News Archive

Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

Medical marijuana dispensaries going corporate

Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

Read more Medical News

› Verified 5 days ago


Dialysis Facility in Portage, IN

FMC - Portage Dialysis Center
Location: 5950 Us Highway 6, Portage, Indiana, 46368
Phone: (219) 762-5731
Davita - Portage
Location: 5823 Us Hwy 6, Portage, Indiana, 46368
Phone: (219) 764-0564
Dialysis Center Of Portage Llc
Location: 5615 Us Highway 6, Portage, Indiana, 46368
Phone: (219) 762-4848

News Archive

Researchers explore nanotechnology's potential to deliver synergistic therapeutics for COVID-19

A team of scientists reviewed the nanoencapsulation approaches of synergistic compounds (Lectins, Caffeine, Cocoa, Flavonoids, Quercetin) and the role of nanotechnology in addressing the COVID-19 pandemic.

Medical marijuana dispensaries going corporate

Medical marijuana dispensaries are going corporate as "more and more states allow medical use of the drug." As "California considers outright legalization, marijuana's supporters are pushing hard to burnish the image of pot by franchising dispensaries and building brands; establishing consulting, lobbying and law firms; setting up trade shows and a seminar circuit; and constructing a range of other marijuana-related businesses."

Phase III studies show Roche's ocrelizumab reduces relapse rate, delays disability progression in MS patients

Three phase III studies being presented at the European Committee for Treatment Research in Multiple Sclerosis congress demonstrate that treating MS with ocrelizumab reduces relapse rate and delay onset of disability progression compared to interferon beta-1a in relapsing forms of MS and disability progression in primary progressive MS compared to placebo.

Researchers discover new molecular mechanism of Alzheimer's disease through protein interaction

Through a complex analysis of protein interactions, researchers from IRB Barcelona and the Joint Programme IRB-BSC have discovered new molecular mechanisms that may be involved in the development of Alzheimer's disease.

BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against H1N1 virus

An independent lab report demonstrated that BIOGUARD™ barrier gauze dressings exhibit greater than 99.9% inactivation rates against swine flu virus after exposure for 24 hours.

Read more Medical News

› Verified 5 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.